CSF2 and nocardiosis: Anti-GM-CSF AAbs have also been described in five otherwise immunocompetent patients with disseminated Nocardia infection [33], and these recent descriptions have expanded the spectrum of clinical presentations in which the presence of anti-GM-CSF antibodies should be sought.